Showing results (1631-1640 of 10,442) with videos related to

Sort By:
Pageof 1,045
AIDS (London, England)|September 2, 2005
Increased thymic output in HIV-negative patients after antiretroviral therapyDaniel B Graham, Michael P Bell, Catherine J Huntoon, et al.
AIDS (London, England)|September 2, 2005
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adultsCurtis L Cooper, Heather L Davis, Jonathan B Angel, et al.
AIDS (London, England)|September 2, 2005
Increased incidence of necrotizing enterocolitis in premature infants born to HIV-positive mothersLuc Desfrere, Isabelle de Oliveira, François Goffinet, et al.
AIDS (London, England)|September 2, 2005
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapineKulkanya Chokephaibulkit, Nottasorn Plipat, Tim R Cressey, et al.
AIDS (London, England)|September 2, 2005
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of TanzaniaMiguel A Arroyo, Michael Hoelscher, Warren Sateren, et al.
AIDS (London, England)|May 13, 2006
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected womenWafaa M El-Sadr, Kenneth H Mayer, Lisa Maslankowski, et al.
AIDS (London, England)|May 13, 2006
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microlEvan Wood, Robert S Hogg, Benita Yip, et al.
AIDS (London, England)|May 13, 2006
Therapy of "SHIV" infected macaques with liposomes delivering antisense interleukin-4 DNANavneet K Dhillon, Sukhbir Dhillon, Yahia Chebloune, et al.
AIDS (London, England)|May 13, 2006
Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimenEsteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
AIDS (London, England)|May 13, 2006
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapyPatrick S Sullivan, Debra L Hanson, Eyasu H Teshale, et al.
Pageof 1,045